✦ LIBER ✦

PHP65 THE IMPACT AND CHALLENGES OF INCLUDING PATIENT COST SHARING IN COST-EFFECTIVENESS ANALYSES FROM THE PAYER PERSPECTIVE

✍ Scribed by DE Spackman; JD Campbell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS34 COST-EFFECTIVENESS OF GOLIMUMAB IN

✍ E Cummins; C Asseburg; M Prasad; J Buchanan; Y Punekar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PHP65 PUBLICATION OF COST-EFFECTIVENESS

✍ D Greenberg; O Wacht; PJ Neumann 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCV73 CONSIDERING THE COST-EFFECTIVENESS

✍ G Koçkaya 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PR3 THE IMPACT OF FINNISH PHARMACEUTICAL

✍ T Hallinen; EJ Soini 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN77 COST-EFFECTIVENESS OF OCTREOTIDE L

✍ ML Takemoto; RA Fernandes; R Chinen; MR Alves 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Cost-utility and budget impact analyses

✍ Sumitra THONGPRASERT; Sirana TINMANEE; Unchalee PERMSUWAN 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB